Trial intelligence / Profile preview

Cannabidiol-rich cannabis ointment for diabetic peripheral neuropathy

RBR-6s85dyjPhase 2Recruiting

Sponsor
Hospital Universitário Pedro Ernesto
Start
Jul 2025
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in diabetic polyneuropathy (DPN) (3 arms), sponsored by Hospital Universitário Pedro Ernesto. Primary endpoints: Safety and systemic effects in phase 1 and Questionnaire-based outcome assessment before and after intervention. Started Jul 2025; status: recruiting.

02

Conditions

diabetic polyneuropathy (DPN)

Beyond the preview

Go deeper on RBR-6s85dyj.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-6s85dyj.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call